Skip to main content
Equibles
CSTL logo

CSTL · Castle Biosciences Inc

Track CSTL — free

Use CSTL with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$33.42 -0.02 (-0.06%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.02B
Shares
30.55M

CSTL metrics

76 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$33.44
Market cap
$1.02B

Price action

19 metrics
Price change (1W)
-4.5%
Price change (30D)
+10.0%
Price change (3M)
+69.7%
Price change (6M)
+21.3%
Price change (YTD)
-14.0%
Price change (1Y)
+39.3%
Trailing year
Price change (5Y)
-55.7%
52-week high
$43.04
52-week low
$18.15
Change from 52-week high
-22.3%
Change from 52-week low
+84.2%
Annualized volatility
57.1%
Beta
1.0
RSI (14D)
61.5
Price vs SMA 50
+20.9%
Price vs SMA 200
+13.6%
Avg volume (3M)
401,624
Relative volume
1.0
Average dollar volume
$10.72M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
30.55M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.1×
reciprocal yield 46.9%
EV / EBITDA
—
EV / EBIT
—
P / sales
2.8×
reciprocal yield 35.1%
P / book
2.2
reciprocal yield 46.2%
FCF yield
0.0%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
23.9
reciprocal yield 4.2%
Earnings yield
-1.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.6×
reciprocal yield 63.3%
EV / revenue historical average (5Y)
1.6×
reciprocal yield 63.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
—
Operating margin
-9.0%
Trailing 12 months
Net margin
-5.4%
Gross profit (TTM)
$57.72M
Operating profit (TTM)
−$32.11M
Net income (TTM)
−$19.41M
Trailing 12 months
Diluted EPS (TTM)
$-0.64
FCF margin
-0.1%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-29.52

Growth

11 metrics
Revenue growth YoY
+20.1%
Year over year
Net income growth YoY
-145.5%
Revenue (TTM)
$357.28M
Trailing 12 months
EPS growth YoY
-146.7%
Shares change YoY
+2.9%
Year over year · more shares
Revenue CAGR (3Y)
+35.9%
Revenue CAGR (5Y)
+40.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
+40.8%

Quality

14 metrics
Return on equity
-4.1%
Return on assets
-3.5%
Debt / equity
0.0
Current ratio
6.0
EBITDA (TTM)
−$16.52M
Free cash flow (TTM)
−$489,000
Quick ratio
5.8
Interest coverage
-85.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$256.73M
Latest balance sheet
Cash & equivalents
$62.12M
Total assets
$561.18M
Total debt
$10.07M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$42.63M
Capital expenditures (TTM)
$43.12M
R&D (TTM)
$55.45M
SG&A (TTM)
$243.66M
Stock compensation (TTM)
$44.87M
R&D / revenue
15.5%
Stock compensation / revenue
12.6%

Ownership (13F)

3 metrics
13F filers
177
13F filer change QoQ
-10
Institutional ownership
89.5%

Short interest

3 metrics
Short interest
5.7%
Latest settlement · 3.7 days to cover
Days to cover
3.7d
Short-squeeze score
61 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$6.72M
Insider-sentiment score
23 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1447362 CUSIP 14843C105 13F (30d) 145 filings 145 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)